|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2025―Jan―18 |
Sustainability amidst pandemic: A qualitative approach on resilience strategies of cut flower farmers during the COVID-19 pandemic in Indonesia |
Rustinsyah Rustinsyah, Muhammad Adib, Ratna Azis Prasetyo, Abdullah Ibrahim |
2 |
[GO] |
2024―Nov―15 |
COVID-19 story: Entry and immune response |
Ali Mohammed Ashraf, Marwan Y. Al-Maqtoofi, Ahmed A. Burghal |
3 |
[GO] |
2024―Oct―24 |
Evaluation of the effect of melatonin on patients with COVID-19 admitted to ICU: A double-blind randomized clinical trial |
Mahmoud Ganjifard, Shokouh Ghafari, Adeleh Sahebnasagh, Mahboubeh Esmaeili, Ali Reza Amirabadizadeh, Azadeh Ebrahimzadeh, et al. (+2) Parvin Askari, Razieh Avan |
4 |
[GO] |
2024―Sep―23 |
Artificial intelligence and COVID-19 vaccine hesitancy |
Sara Kamal Shahsavar, Arman Alinezhad, Masoud Keikha |
5 |
[GO] |
2024―Jul―31 |
Psychological characteristics and their impact on the efficacy and safety of COVID-19 vaccines |
Mohsen Karbalaei, Vahideh Poyesh, Masoud Keikha |
6 |
[GO] |
2024―Jul―17 |
Association of C4 and CH50 levels with cough and rhinorrhea in COVID-19 patients: A retrospective analysis in the Iranian population |
Seyed Ali Hashemi, Forouzan Rostami, Babak Shaghaghi, Mahla Niknam, Elham Abani, Abdol Sattar Pagheh, et al. (+2) Arezou Khosrojerdi, Fatemeh Rezaei |
7 |
[GO] |
2024―Jun―28 |
Social media as a supporting mechanism during COVID-19 in Indonesia: A quantitative study on isolation among elders |
Mustain Mashud, Muhammad Saud, Rachmah Ida, Asia Ashfaq |
8 |
[GO] |
2024―Jun―25 |
Importancia de las agencias reguladoras nacionales y los laboratorios nacionales de control ante la pandemia de COVID-19: experiencia de la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) |
Imelda Rocío Guzmán-Cervantes, Elías Parra-Hernández, Alejandro Ernesto Svarch-Pérez, Armida Zúñiga-Estrada, Jorge C. Alcocer-Varela |
9 |
[GO] |
2024―May―22 |
Efecto de la vacunación contra el SARS-CoV-2 sobre la coagulación en pacientes mayores de 60 años tratados con acenocumarol |
Isabel Almodóvar-Fernández, Antonio Real-Fernández, Manuel Jesús Romero Atanes, Carlos Andreu-Vilarroig, Miguel Ángel Beltrán-Viciano, María Francisca Monreal-Pérez |
10 |
[GO] |
2024―May―09 |
COVID-19 vaccination and concerns regarding the maternal and neonatal safety outcomes |
Abdolreza Narouiepour, Mohsen Karbalaei, Masoud Keikha |
11 |
[GO] |
2024―Apr―15 |
COVID-19 vaccine rumour and resistance in Indonesia: Analysing vaccine hesitancy and cultural myths circulated on online platforms |
Rachmah Ida, Sri Endah Kinasih, Syafrida Nurrachmi Febriyanti, Ratih Puspa, Muhammad Saud, Mohd Syuhaidi Abu Bakar |
12 |
[GO] |
2024―Mar―28 |
Analysis of the level of protective serum antibody after third dose of different COVID-19 vaccines |
Atena Mansouri, Mitra Rafiee, Seyed-Alireza Esmaeili, Saboura Nikpour, Alireza Fereidouni, Mohammad Fereidouni |
13 |
[GO] |
2024―Mar―20 |
The impact of Omicron on the COVID-19 vaccines: A review |
Pragya D. Yadav, Deepak Y. Patil, Rima R. Sahay, Anita M. Shete, Sreelekshmy Mohandas, Velu Nair |
14 |
[GO] |
2024―Mar―07 |
Post COVID-19 era: Re-emergence of known and future (X) viral pathogens |
Pryanka Thakur, Vikram Thakur, Monika Sapra, Sonakshi Srivastava, Sanjay Kumar Singh Patel |
15 |
[GO] |
2024―Mar―05 |
Vacunación COVID-19 y búsquedas web sobre salud mental: un estudio infodemiológico mundial |
Juan Antonio Becerra-García, Sara Barbeito, Teresa Sánchez-Gutiérrez |
16 |
[GO] |
2024―Feb―15 |
Mecanismos inmunitarios innatos y adaptativos de las vacunas COVID-19. Efectos adversos graves asociados a la vacunación contra el SARS-CoV-2: una revisión sistemática |
Rocío Morlanes Pallás |
17 |
[GO] |
2024―Jan―18 |
Variantes genéticas rs1800629 en TNF y rs2228145 en IL6R: asociación con eventos supuestamente atribuibles a la vacunación e inmunización (ESAVI) y anticuerpos neutralizantes contra SARS-CoV-2 en la población del occidente de México vacunada con AZD1222 |
Axel Jair Villa-Panduro, Narda M. Corona-Reynaga, Dennis A. Meza-Peña, Mayra Alejandra Enciso Ramírez, Astrid Selene Espinoza García, Jorge Galindo-García, et al. (+4) Berenice Sanchez-Caballero, Elia Herminia Valdés-Miramontes, José Francisco Muñoz-Valle, Zyanya Reyes-Castillo |
18 |
[GO] |
2024―Jan―11 |
Knowledge, attitudes, and adherence of the Cape Verdean population to the COVID-19 vaccine |
Maria de Fátima Carvalho Alves, Janice de Jesus Soares, Maria da Luz Lima Mendonça |
19 |
[GO] |
2023―Dec―12 |
Exploring the psychological impact of anxiety, depression, and quality of life in patients with comorbid disease conditions post COVID-19 pandemic era |
Anmar Al-Taie, Dania A. Mohd Khalaf, Oritsetimeyin Arueyingho |
20 |
[GO] |
2023―Nov―28 |
Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform |
Fahime Edalat, Fatemeh Hosseini Tabatabaie, Afagh Moattari, Arash Letafati, Jamal Sarvari, Seyed Younes Hosseini |
21 |
[GO] |
2023―Nov―10 |
The prevalence of post-COVID-19 vaccination syndrome and quality of life among COVID-19-vaccinated individuals |
Yogendra Shrestha, Rajesh Venkataraman |
22 |
[GO] |
2023―Oct―16 |
Musculoskeletal and neuromuscular dysfunction due to covid-19 infection: A review |
Vivek Chauhan, Akash Pandey, Adrija Rakshit, Gaytri Mahajan, Shamsher S. Kanwar, Vivek Kumar Dhiman, Devendra Singh |
23 |
[GO] |
2023―Oct―05 |
Attitudes and concerns of Turkish nursing students against the COVID-19 vaccine, willingness to be vaccinated: A cross-sectional study |
Zeynep Daşıkan, Mashood Katuntu Waiswa |
24 |
[GO] |
2023―Oct―05 |
Impacto de la vacunación en la mortalidad de adultos colombianos con síndrome de dificultad respiratoria aguda por SARS-CoV-2 que requirieron ventilación mecánica invasiva |
Yina Daniela Benítez Patiño, Luis Carlos Triana, Oscar Mauricio Muñoz Velandia, Viviana Yiset López Ramírez, Laura María Niño Guerra, Santiago Bottia Córdoba |
25 |
[GO] |
2023―Oct―05 |
The co-infection of SARS-CoV-2 with atypical bacterial respiratory infections: A mini review |
Fateme Taheri, Soheil Vesal, Parnian Goudarzi, Zahra Sahafnejad, Amin Khoshbayan |
26 |
[GO] |
2023―Sep―15 |
Vacunación frente al SARS-CoV-2 en otoño de 2023: ¿a quién y cómo hay que vacunar? |
Fernando Moraga-Llop, Magda Campins-Martí |
27 |
[GO] |
2023―Aug―31 |
COVID-19 vaccines, perceptions and trust amongst vaccine refusers: A qualitative thematic analysis study |
Deldar Morad Abdulah, Hawar Abdulrazaq Mohammedsadiq, Pranee Liamputtong |
28 |
[GO] |
2023―Aug―30 |
To assess mortality from COVID-19 in patients with comorbidities, it is crucial to perform an autopsy |
Josef Finsterer |
29 |
[GO] |
2023―Aug―30 |
Vaccination impact on long COVID sequelae; a perspective view |
Farhad Dadgar, Fatemeh Dehghani, Farzaneh Peikfalak, Masoud Keikha |
30 |
[GO] |
2023―Jun―29 |
Exploring the Intention and Hesitancy to Receive a Booster Dose of COVID-19 Vaccine among Patients with Comorbid Disease Conditions Using a Health Belief Model. |
Anmar AL-TAIE, Zekiye K. YILMAZ |
31 |
[GO] |
2023―Jun―24 |
Epidemiological study of vaccination against SARS-CoV-2 and its impact on COVID-19 progression in a cohort of patients in gran Canaria |
Alejandro de Arriba Fernández, José Luis Alonso Bilbao, Alberto Espiñeira Francés, Antonio Cabeza Mora, Ángela Gutiérrez Pérez, Miguel Ángel Díaz Barreiros |
32 |
[GO] |
2023―May―26 |
Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece. |
Petros Galanis, Aglaia Katsiroumpa, Irene Vraka, Vanessa Chrysagi, Olga Siskou, Olympia Konstantakopoulou, et al. (+3) Theodoros Katsoulas, Parisis Gallos, Daphne Kaitelidou |
33 |
[GO] |
2023―May―18 |
ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION AMONG PREGNANT WOMEN ATTENDING PRIMARY HEALTH CENTERS: AN ACTIVE-SURVEILLANCE STUDY. |
Narayana Goruntla, Basappa Karisetty, N. Nandini Reddy, Bharadwaj Bhupasamdram, Himaja Reddy Ganireddy, Kasturi Vishwanathasetty Veerabhadrappa, et al. (+2) Joseph Obiezu Chukwujekwu Ezeonwumelu, Vishnuvandana Bandaru |
34 |
[GO] |
2023―May―18 |
COVID-19 Immune Response In Adults Post Measles-Rubella Vaccination. |
Suwoyo Suwoyo, Erna Rahma Yani, Koekoeh Hardjito |
35 |
[GO] |
2023―May―18 |
El fin de la urgencia internacional de salud pública por COVID-19: ¿y ahora qué? |
Núria Torner |
36 |
[GO] |
2023―May―04 |
Impact of Vaccination on the Entire Population and Dose-Response Relation of COVID-19 |
Abdul Malek, Ashabul Hoque |
37 |
[GO] |
2023―Apr―25 |
The status of COVID-19 vaccines in India: A Review. |
Deepak Kumar Jha, Kumar Pranay, Amit Kumar, Niti Yashvardhini |
38 |
[GO] |
2023―Apr―10 |
The Polymorphisms of TNF-α Related-gene and Antibody Production Following Third Dose of COVID-19 Vaccination: A Pilot Study. |
Phey Liana, Zen Hafy, Soilia Fertilita, Ella Amalia, Veny Larasati, Tungki Pratama Umar |
39 |
[GO] |
2023―Mar―06 |
IMPACTO DE LA VACUNACIÓN CONTRA SARS-CoV-2 EN LA INCIDENCIA DE INFECCIÓN EN ÁMBITO ESCOLAR. |
María Teresa Herrero Diez, María Inés Salado Valdivieso, Sara Carbajal Domínguez, Marta Allué Tango, Juan Carlos Villa Caballero, Clara Berbel Hernández |
40 |
[GO] |
2023―Mar―02 |
An immunoinformatics approach to study the epitopes of SARS-CoV-2 helicase, Nsp13. |
Sushant Kumar, Khushboo Kumari, Gajendra Kumar Azad |
41 |
[GO] |
2023―Feb―13 |
Demographic and clinical characteristics and outcomes of COVID-19 patients admitted to a university hospital in the west of Iran: a retrospective study in the third wave. |
Younes Jesmani, Arezoo Bozorgomid, Fatemeh Khosravi Shadmani, Ali Dehbani, Babak Sayad |
42 |
[GO] |
2023―Jan―25 |
Incidence of sudden sensorineural hearing loss associated with BNT162b2 COVID-19 vaccine: Pooled results from register-based nationwide studies |
Paulo Ricardo Martins-Filho |
43 |
[GO] |
2023―Jan―17 |
FACTORES ASOCIADOS A LA INTENCIÓN DE VACUNACIÓN CONTRA EL COVID-19, EN POPAYÁN, CAUCA COLOMBIA |
Omar Andrés Ramos Valencia, Yuliana Buitrón Gonzalez, Jorge Sotelo Daza, Andrés Felipe Villaquiran |
44 |
[GO] |
2022―Dec―27 |
Optic neuritis associated with COVID-19-related vaccines |
Masoud Keikha, Mehdi Zandhaghighi, Shahram Shahraki Zahedani |
45 |
[GO] |
2022―Dec―26 |
Vacunación frente a la COVID-19 a partir de los 6 meses de edad. Completando el círculo de la prevención en pediatría. |
Fernando Moraga-Llop |
46 |
[GO] |
2022―Dec―13 |
Knowledge And Attitudes Toward the COVID-19 Vaccine Among India's General Rural Population |
Rajesh Venkataraman, Umesh Yadav, Yogendra Shrestha, Sindhu Shree Narayanaswamy, Shree Harsha Pura Basavaraju |
47 |
[GO] |
2022―Nov―04 |
Determination of Binding Affinity of Tunicamycin with SARS-CoV-2 Proteins: Proteinase, Protease, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, Envelope and RBD of Spike Glycoprotein |
Ali Adel Dawood |
48 |
[GO] |
2022―Nov―01 |
The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19 |
Ali AliMohammadi, Nahid Chazani-Sharahi, Zahra Asgari Hezaveh, Elnaz Abbasi, Aref Shariati, Ehsanollah Ghaznavi-Rad |
49 |
[GO] |
2022―Nov―01 |
Differences in elderly stress levels before Covid-19 vaccination: History of exposure to Covid-19 reduces stress before vaccination |
Kristian Budi Setiawan, Isna Hikmawati, Dita Pratiwi Kusuma Wardani, Juanita Juanita |
50 |
[GO] |
2022―Oct―19 |
IR-7968. Enfermedad invasiva por neumococo en 2021. Impacto de la pandemia de COVID-19 |
C. Izquierdo Gómez, N. Soldevila Pidemunt, J. García-García, B. Viñado, A. Díaz-Conradi, Grupo de trabajo Barcino |
51 |
[GO] |
2022―Oct―19 |
IE-7919. Reticencias vacunales COVID-19 |
M.C. Gómez Moreno, M.B. Laorden Ochando, S. Sánchez Manresa, M. Pérez Martínez, M. Zornoza Moreno, J.J. Pérez Martín |
52 |
[GO] |
2022―Oct―19 |
IE-7884. Inmunogenicidad de una vacuna de proteína recombinante contra el SARS-CoV-2 (PHH-1V) como refuerzo heterólogo en individuos previamente vacunados contra la COVID-19 |
S. de Cambra Florensa, J. Corominas Garia, M.T. Prat Cabañas, E. Torroella Busquets |
53 |
[GO] |
2022―Oct―19 |
IE-7881. Reactogenicidad de una vacuna de proteína recombinante contra el SARS-CoV-2 (PHH-1V) como refuerzo heterólogo: diferencias según la vacunación primaria previamente recibida y según el historial de infección de COVID-19 |
C. Borralleras Fumaña, J. Corominas García, M.T. Prat Cabañas, L. Ferrer Soler, I. Güell Casellas, E. Torroella Busquets |
54 |
[GO] |
2022―Oct―19 |
IE-7717. Los Servicios de Urgencias como aliados en la notificación de sospecha de reacciones adversas asociadas a la vacunación COVID-19 |
I. González-Iglesias, M. Fernández-Prada, E. Martín-Aragonés, P. Penanes-Alonso, P. Cienfuegos-González, M.J. Zapico-Baragaño |
55 |
[GO] |
2022―Oct―19 |
IR-7922. Comparación de 2 brotes de COVID-19 acaecidos antes y después de la vacunación de usuarios y trabajadores de una residencia geriátrica |
G. Parisé Farreny, J. Rosinach Bonet, N. Rosell Solé, J.P. Bamala Zuriguel, I. Mòdol Pena, X. Farré Pueyo |
56 |
[GO] |
2022―Oct―19 |
EE-7888. Campaña de captación (catch-up) con COVID-19 en gestantes: implementación y resultados |
M. Fernández-Prada, A. Sánchez del Río, C.I. González-González, E. Martín-Aragonés, L. López-Fernández, P. Cienfuegos-González |
57 |
[GO] |
2022―Oct―19 |
ER-7932. Experiencia de vacunación frente al COVID-19 en las personas de muy alto riesgo en el Servicio de Medicina Preventiva y Salud Pública de un hospital de tercer nivel |
N. Manrique Vinagre, M.M. Guerra Hernández, V. Fernández Espinilla, N. Khynku Khshyva, C. De Álvaro García, M. Martínez Retortillo |
58 |
[GO] |
2022―Oct―19 |
IR-7936. Características epidemiológicas de las reinfecciones por COVID-19 en los trabajadores sanitarios |
A. Pérez Dalí, R. García Rodríguez, M.J. Pereira Rodríguez, I. Díaz Vázquez, F. Freijedo Fariñas, M.M. Castro Rivas |
59 |
[GO] |
2022―Oct―19 |
EE-7853. Campaña de captación (catch-up) con COVID-19 en pacientes hospitalizados: implementación y resultados |
P. Cienfuegos-González, E. Madrid-Álvarez, M. Fernández-Prada, M.J. Zapico-Baragaño, E. Martín-Aragonés, L. López-Fernández |
60 |
[GO] |
2022―Oct―19 |
ER-7972. Características de los profesionales vacunados frente al COVID-19 en un hospital de tercer nivel |
E. García Carrasco, D.M. López Garizado |
61 |
[GO] |
2022―Oct―19 |
EE-7978. Implementación de la campaña de vacunación frente a COVID-19 en un hospital de tercer nivel |
L.P. Cabrera-Miranda, A. García De Codes Ilario, S. de Miguel García, N. Rosillo Ramírez, E.M. Medrano Monteagudo, M.P. Gil Martínez, M.P. Arrazola Martínez |
62 |
[GO] |
2022―Oct―19 |
IE-7971. Perfil clínico y demográfico de los pacientes candidatos a recibir Evusheld® para la prevención de la COVID-19 grave, en un hospital de tercer nivel |
E. García Verduguez, N. Rosillo Ramírez, S. de Miguel García, A. García de Codes, L.P. Cabrera Miranda, P. Arrazola Martínez |
63 |
[GO] |
2022―Oct―19 |
IR-7641. Cobertura vacunal antineumocócica en pacientes mayores de 65 años hospitalizados por la enfermedad de SARS-CoV-2 |
M.T. Herrero Díez, M.M. Guerra Hernández, V. Fernández Espinilla, M.C. Viña Simón, C. Hernán García, J.J. Castrodeza Sanz |
64 |
[GO] |
2022―Oct―19 |
IE-7951. Evolución epidemiológica de los nuevos serotipos vacunales 22F y 33F de Streptococcus pneumoniae en España incluyendo el impacto de la pandemia por SARS-CoV-2 |
J. Sempere, S. Ruiz, D. Rico, S. de Miguel, M. Domenech, J. Yuste |
65 |
[GO] |
2022―Oct―19 |
IE-7950. Contribución de las vacunas conjugadas antineumocócicas y el SARS-CoV-2 a la resistencia a antibióticos en Streptococcus pneumoniae en España durante el periodo 2004-2020 |
J. Sempere, C. Pérez-García, D. Lago, S. Hita, M. Domenech, J. Yuste |
66 |
[GO] |
2022―Oct―19 |
IE-7967. Respuesta a la vacunación frente a SARS-CoV-2 con vacunas de ARNm en los pacientes inmunodeprimidos |
N. Rosillo Ramírez, A. García de Codes, L.P. Cabrera Miranda, S. de Miguel García, E. García Verduguez, P. Arrazola Martínez |
67 |
[GO] |
2022―Oct―19 |
IE-7925. Contribución de las vacunas antineumocócicas y la pandemia por SARS-CoV-2 en la evolución epidemiológica de la enfermedad neumocócica invasiva en España |
S. de Miguel, J. Sempere, S. Hita, J. Llorente, M. Domenech, J. Yuste |
68 |
[GO] |
2022―Oct―19 |
IR-7885. Seguridad de una vacuna de proteína recombinante basada en un heterodímero de fusión del dominio de unión al receptor del SARS-CoV-2 (PHH-1V) como primovacunación en adultos sanos en Vietnam |
S. de Cambra Florensa, C. Garriga Alsina, L. Ferrer Soler, E. Torroella Busquets |
69 |
[GO] |
2022―Oct―19 |
IR-7883. Inmunogenicidad de una vacuna de proteína recombinante contra el SARS-CoV-2 (PHH-1V) como primovacunación en adultos sanos en Vietnam |
C. Borralleras Fumaña, C. Garriga Alsina, L. Ferrer Soler, E. Torroella Busquets |
70 |
[GO] |
2022―Oct―04 |
Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective study |
Fazlollah Shokri, Saeed Rezapoor, Masoud Najafi, Mohsen Asadi, Mohammad Karimi alavije, Moussa Abolhassani, et al. (+9) Mohammad Hossein Moieneddin, Amir Muhammad Ashrafi, Narges Gholipour, Parisa Naderi, Jamshid Yazdani Charati, Reza Alizadeh-Navaei, Majid Saeedi, Mohsen Heidary, Mostafa Rostamnezhad |
71 |
[GO] |
2022―Sep―16 |
Vaccine hesitancy and the challenge of controlling COVID-19 and other vaccine-preventable diseases |
Paulo Ricardo Martins-Filho |
72 |
[GO] |
2022―Aug―30 |
Evaluating the characteristics of patients with SARS-CoV-2 infection admitted during COVID-19 peaks: A single-center study |
Seyede Faezeh Mousavi, Mohammadamin Ebrahimi, Seyed Amirhosein Ahmadpour Moghaddam, Narges Moafi, Mahbobe Jafari, Ayoub Tavakolian, Mohsen Heidary |
73 |
[GO] |
2022―Aug―30 |
Parents' perception of COVID-19 risk of infection and intention to vaccinate their children |
Hamdy Khaled Sabra, Mostafa Abdulraheem Bakr, Omar El Sayed Mohmed Rageh, Asmaa Khaled, Omnia Mohamed Elbakliesh, Ibrahim Ali Kabbash |
74 |
[GO] |
2022―Jul―19 |
Vacunaciones masivas contra el COVID-19 mediante el uso de las tecnologías para la gestión de la programación de citas y datos de grandes volúmenes de vacunados |
Alicia K. Rodas-Martinez, Josue R. Altamirano-Yupanqui |
75 |
[GO] |
2022―Jul―19 |
Menstrual abnormalities after COVID-19 vaccines: A systematic review |
Maheen Nazir, Shumaila Asghar, Muhammad Ali Rathore, Asima Shahzad, Anum Shahid, Alishba Ashraf Khan, et al. (+4) Asmara Malik, Tehniat Fakhar, Hafsa Kausar, Jahanzeb Malik |
76 |
[GO] |
2022―Jul―04 |
Reasons for Individuals' COVID-19 vaccine hesitations and changing decisions over time: A longitudinal qualitative study |
Dicle Filiz Yıldırım, Pınar Serçekuş, Sevgi Özkan |
77 |
[GO] |
2022―Jun―22 |
COVID-19 Vaccines: Update of the vaccines in use and under development |
Rafaela Angotti Marta, Gisele Emy Kondo Nakamura, Bruno de Matos Aquino, Paulo R. Bignardi |
78 |
[GO] |
2022―Jun―20 |
COVID-19 vaccination acceptance in Jambi City, Indonesia: A single vaccination Center study |
Gilbert Sterling Octavius, Theo Audi Yanto, Rivaldo Steven Heriyanto, Haviza Nisa, Catherine Ienawi, H. Emildan Pasai |
79 |
[GO] |
2022―Jun―17 |
Multivalent vaccines against new SARS-CoV-2 hybrid variants |
Kiarash Ghazvini, Masoud Keikha |
80 |
[GO] |
2022―Jun―17 |
Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
Masoud Keikha |
81 |
[GO] |
2022―Jun―09 |
Implementation of immuno-chemoinformatics approaches to construct multi-epitope for vaccine development against Omicron and Delta SARS-CoV-2 variants |
Ali Adel Dawood |
82 |
[GO] |
2022―Jun―03 |
Early diagnosis and treatment of SARS-CoV-2 vaccination associated polyradiculitis to improve the outcome |
Josef Finsterer, Fulvio A. Scorza |
83 |
[GO] |
2022―Jun―01 |
Comparison of clinical, radiological and laboratory findings in discharged and dead patients with COVID-19 |
Mahbobe Jafari, Maryam Akbari, Maryam Navidkia, Shirin Dashtbin, Seyede Faezeh Mousavi, Mohsen Heidary, Saeed Khoshnood |
84 |
[GO] |
2022―Jun―01 |
COVID-19 vaccination coverage and associated factors in seasonal fruit workers in Lleida |
Carme Miret, Miquel Alsedà, Pere Godoy |
85 |
[GO] |
2022―May―30 |
Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain |
Christine Giesen, Carmen Saa-Requejo, Inmaculada Lopez-Carrillo, Angelica Ortega-Torres, Cristina García-Fernández |
86 |
[GO] |
2022―May―13 |
Intention to get COVID-19 vaccination and its associated predictors: A cross-sectional study among the general public in Algeria |
Mohamed Lounis, Samir Abdelhadi, Mohammed Amir Rais, Djihad Bencherit, Malik Sallam |
87 |
[GO] |
2022―Apr―28 |
Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online survey in Greece |
Petros Galanis, Irene Vraka, Olga Siskou, Olympia Konstantakopoulou, Aglaia Katsiroumpa, Ioannis Moisoglou, Daphne Kaitelidou |
88 |
[GO] |
2022―Apr―28 |
Lack of COVID-19 vaccination in rural areas of Pakistan |
Alisha Saleem, Maha Rashid, Ameerah Shaikh, Sajjad Ali |
89 |
[GO] |
2022―Mar―24 |
The prevalence of inverse health consequences of COVID-19 vaccines: a post-vaccination study |
Yogendra Shrestha, Rajesh Venkataraman |
90 |
[GO] |
2022―Feb―14 |
Evaluación de la respuesta de anticuerpos IGG específicos contra SARS-COV-2 en personal de salud con esquema completo de vacuna sputnik V (GAM-COVID-VAC) |
Ezequiel Cordova, M. Ines Lespada, Diego Cecchini, Fabiola Nieto, Susana Palonski, Mariana Badran, et al. (+8) Silvina Bernasconi, Brenda Bacelar, Laura Morganti, Franco Garibaldi, Veronica Bermejo, Viviana Aguirre, Marcela Badia, Claudia G. Rodriguez |
91 |
[GO] |
2022―Feb―11 |
Vacunación pediátrica frente a la COVID-19 más allá de la adolescencia. Otra realidad |
F. Moraga-Llop |
92 |
[GO] |
2022―Feb―02 |
Awareness, knowledge and acceptance of COVID-19 vaccine among the people of West Bengal, India: A web-based survey |
Sovan Samanta, Jhimli Banerjee, Suvrendu Sankar Kar, Kazi Monjur Ali, Biplab Giri, Amitava Pal, Sandeep Kumar Dash |
93 |
[GO] |
2022―Jan―26 |
Adenoviral vector-based COVID-19 vaccines-associated cerebral venous sinus thromboses: Are those adverse events related to the formation of neutrophil extracellular traps? |
Marian Simka |
94 |
[GO] |
2022―Jan―25 |
La GESTIÓN de la PANDEMIA de COVID-19 EN las RESIDENCIAS GERIÁTRICAS de CATALUÑA |
F.E.R.N.A.N.D.O. PARRILLA |
95 |
[GO] |
2022―Jan―06 |
Selection of new COVID-19 genotypes following mass vaccination: The Rotavirus model |
Pierfrancesco Lapolla, Pietro Familiari, Placido Bruzzaniti |
96 |
[GO] |
2021―Dec―03 |
Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies |
Niti Yashvardhini, Amit Kumar, Deepak Kumar Jha |
97 |
[GO] |
2021―Nov―04 |
Asociación entre la vacunación contra influenza y la mortalidad por COVID-19 |
Cesar A Arce-Salinas, Yamile N Esquivel-Torruco, Arely A Bejarano-Juvera, Aditi K Bustamante- Flores, Naomi Aguilar-Martínez, Jessica G Azcorra- López, et al. (+4) Berenice Cabañas-Espinosa, Eva M Luna-Rivera, Adriana Hernández-Alarcón, Jesús Reyna Figueroa |
98 |
[GO] |
2021―Nov―04 |
Is there any effect of flu vaccine on the SARS-CoV-2 infected patients? |
D. El-Qutob, M. Nieto, L. Alvarez-Arroyo, FJ Carrera-Hueso |
99 |
[GO] |
2021―Sep―07 |
Zinc role in Covid-19 disease and prevention |
Alberto Boretti, Bimal K Banik |
100 |
[GO] |
2021―Sep―07 |
Assessment of attitude and hesitancy towards vaccine against COVID-19 in a Pakistani population: A mix methods survey |
Zainab Aqeel Khan, Raheel Allana, Irrum Afzal, Akbar Shoukat Ali, Omama Mariam, Reema Aslam, et al. (+8) Imran Ali Shah, Asad Allana, M. Mohsin Haider, Rahim Jandani, Zeeshan Khan, Athar M Siddiqui, Junaid Ali Shah, Umer Butt |
101 |
[GO] |
2021―Sep―07 |
Predictive demographic factors of Covid-19 vaccine hesitancy in Venezuela: a cross-sectional study |
Gabriel Andrade |
102 |
[GO] |
2021―Sep―06 |
Attitudes of a Sample of Jordanian Young Adults toward Different Available COVID-19 Vaccines |
Walid Al-Qerem, Anan S Jarab, Raghda Qarqaz, Mohammad Al Hayek |
103 |
[GO] |
2021―Sep―01 |
Factors influencing the acceptability of COVID-19 vaccination: A cross-sectional study from Malaysia |
Roy Rillera Marzo, Absar Ahmad, Khadijah Abid, Asmita Priyadashini Khatiwada, Ali Ahmed, Thin Mon Kyaw, et al. (+5) Insyirah Bt Zainal Abidin, Metahra Srithar, Sathiajothi Sinnathamby, Arivalagan Palani Sarvasundram, Sunil Shrestha |
104 |
[GO] |
2021―Aug―04 |
COVID-19 and primary care: a perspective from Italy |
F Ghidinelli, F Martire |
105 |
[GO] |
2021―Aug―04 |
Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021 |
Nelson Alvis-Guzman |
106 |
[GO] |
2021―Jul―13 |
Diagnosis Of Covid-19 In Symptomatic Patients: An Updated Review |
MN Zahan, H. Habibi, A. Pencil, J. Abdul-Ghafar, SA Ahmadi, NS Juyena, et al. (+2) MT Rahman, MS Parvej |
107 |
[GO] |
2021―Jul―13 |
Variantes de SARS-CoV-2, una historia todavía inacabada |
Marta Pérez-Abeledo, Juan Carlos Sanz |
108 |
[GO] |
2021―Jun―17 |
Discordant results of SARS-CoV-2 PCR-based tests in the early phase of pandemic in Indonesia: infection control consequences |
Agung Pranata, Baidillah Zulkifli, Sukmawan Fajar Santosa, Ade Oktiviyari, Zulfitri Zulfitri, Zinatul Hayati, et al. (+3) Mudatsir Mudatsir, Ichsan Ichsan, Harapan Harapan |
109 |
[GO] |
2021―May―28 |
Vacunación frente a la COVID-19 en los adolescentes. Una realidad |
Fernando Moraga-Llop |
110 |
[GO] |
2021―May―19 |
“Recomendaciones SEPAR y nuevos retos sobre la vacuna COVID-19 en las enfermedades respiratorias” |
David de la Rosa-Carrillo, José Luis López-Campos, Marina Blanco Aparicio, Felipe Villar-Álvarez |
111 |
[GO] |
2021―Apr―15 |
Los gobiernos y la vacunación contra la COVID-19 |
Mag Luz Javier |
112 |
[GO] |
2021―Apr―09 |
Impacto de las variantes genéticas de la espícula en las vacunas frente al SARS-CoV-2 |
Jordi Reina, Pablo Fraile-Ribot |
113 |
[GO] |
2021―Apr―05 |
Retrospective and prospective application of robots and artificial intelligence in global pandemic and epidemic diseases |
A. Yoganandhan, G. Rajesh Kanna, S.D. Subhash, J. Hebinson Jothi |
114 |
[GO] |
2021―Mar―12 |
Myths and conspiracy theories on vaccines and COVID-19: Potential effect on global vaccine refusals |
Irfan Ullah, Kiran Shafiq Khan, Muhammad Junaid Tahir, Ali Ahmed, Harapan Harapan |
115 |
[GO] |
2021―Feb―26 |
The Vaccine-Condition Or Vaccination Passport And Its Eventual Fit Into A Broad Recommended Vaccination Framework Against Covid-19 |
César Cierco Seira |
116 |
[GO] |
2021―Jan―22 |
The role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic |
Alessandra La Gatta, Federico Ghidinelli |
117 |
[GO] |
2020―Nov―25 |
Mareo al volar irresoluble asociado a la infección por COVID-19: caso clínico |
Hamze Shahali, Amin Talebi Bezmin Abadi, Azade Amirabadi Farahani, Mohammad Darvishi |
118 |
[GO] |
2020―Oct―14 |
¿Cómo será la segunda ola del terrible COVID-19 con el número creciente de casos infectados y mortalidad en Iraq? |
Ali Adel Dawood, Zahra Adel Dawood |
119 |
[GO] |
2020―Oct―14 |
Novel Coronavirus 2019 (COVID-19) Pandemic Outbreak: A Comprehensive Review of the Current Literature |
Hayat Ullah, Asad Ullah, Anbareen Gull, Tayyaba Mousavi, Muhammad Waseem Khan |
120 |
[GO] |
2020―Oct―03 |
Glicosilación, sitios de unión de ligandos y variaciones antigénicas entre la glicoproteína de membrana del COVID-19 y los coronavirus asociados |
Ali Adel Dawood |
121 |
[GO] |
2020―Sep―14 |
Tendencias epidémicas en los diez principales países con más casos de COVID-19 en comparación con Turquía |
Veli Durmuş |
122 |
[GO] |
2020―Sep―12 |
Are social distancing, hand washing and wearing masks can mitigate the transmission of COVID-19? |
Natesan Manikandan |
123 |
[GO] |
2020―Jul―04 |
Recuperando las coberturas vacunales perdidas en la pandemia COVID-19 |
F.A. Moraga-Llop, M. Fernández-Prada, A.M. Grande-Tejada, L.I. Martínez-Alcorta, D. Moreno-Pérez, J.J. Pérez-Martín |
124 |
[GO] |
2020―Jul―04 |
Collateral effects of Covid-19 pandemic emergency response on worldwide immunizations |
Nuria Torner |
125 |
[GO] |
2020―Jun―13 |
A review on Promising vaccine development progress for COVID-19 disease |
Tafere Mulaw Belete |
126 |
[GO] |
2020―Apr―18 |
Vacunas contra el coronavirus |
L. Urbiztondo, E. Borras, G. Mirada |
127 |
[GO] |
2020―Apr―04 |
El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo |
J. Reina |